Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Stock Watch: SIGA Opens The Week With A Bang
Seeking Alpha
Tuesday, March 27, 2012 - 10:39am
tags:
SIGA technologies, PharmAthene
Drug companies watching India’s drug patent case
Globe and Mail, Canada
Tuesday, March 27, 2012 - 10:09am
tags:
patents, India, Novartis
Antidepressants give drugmakers the blues
Reuters
Tuesday, March 27, 2012 - 10:07am
tags:
antidepressants, Targacept, AstraZeneca, GSK
Targacept reports mixed data from two trials
Reuters
Tuesday, March 27, 2012 - 10:06am
tags:
Targacept, diabetes, asthma, TC-6987
Dynavax reports final Phase 3 data for HEPLISAV
Yahoo/Fly on the Wall
Tuesday, March 27, 2012 - 10:05am
tags:
Heplisav, Dynavax, chronic kidney disease
Why the Street Should Love Endo Pharmaceuticals' Earnings
Motley Fool
Tuesday, March 27, 2012 - 10:03am
tags:
earnings, Endo
Bausch & Lomb to buy Ista Pharma in $500 mln deal
Marketwatch
Tuesday, March 27, 2012 - 9:21am
tags:
M&A, ISTA Pharmaceuticals, Bausch & Lomb
ISTA Pharmaceuticals Gets The Bid It Wants
Seeking Alpha
Tuesday, March 27, 2012 - 9:17am
tags:
Vertex Pharmaceuticals, Novartis, ISTA Pharmaceuticals, Allergan, Bausch & Lomb, M&A
MAP Pharma shares dive after FDA rejects migraine drug
Reuters
Tuesday, March 27, 2012 - 9:15am
tags:
FDA, migraines, MAP Pharmaceuticals
Abbott Laboratories Split Will Make The Perfect Team For Investors
Seeking Alpha
Tuesday, March 27, 2012 - 9:14am
tags:
Abbott Laboratories, investors, AbbVie
Is Pfizer Pfinished?
Seeking Alpha
Monday, March 26, 2012 - 9:24pm
tags:
Pfizer, Abbott Laboratories, JNJ
Will the FDA Approve Affymax's Peginesatide?
Motley Fool
Monday, March 26, 2012 - 9:23pm
tags:
FDA, Affymax, peginesatide, anemia
Ala. judge sets trial dates for suits over Chantix
Yahoo/AP
Monday, March 26, 2012 - 9:22pm
tags:
Chantix, Alabama, Pfizer
J&J Goes Back To Texas Court Over Risperdal
Pharmalot
Monday, March 26, 2012 - 12:43pm
tags:
Texas, JNJ, Risperdal
Arena Pharma says EU is reviewing weight loss drug
Yahoo/AP
Monday, March 26, 2012 - 12:42pm
tags:
Arena, lorcaserin, Europe, obesity
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
Monday, March 26, 2012 - 12:22pm
tags:
obesity, Vivus, Arena Pharmaceuticals, Orexigen, Qnexa
VIVUS Announces Acceptance of Avanafil Application in Europe
Yahoo
Monday, March 26, 2012 - 12:20pm
tags:
Vivus, Avanafil, Europe, erectile dysfunction
Monthly shots of Amgen drug slash cholesterol up to 66 pct
Reuters
Monday, March 26, 2012 - 12:19pm
tags:
Amgen, AMG145, PCSK9 inhibitor
Opportunity On The Horizon For Discovery Laboratories Investors
Seeking Alpha
Monday, March 26, 2012 - 12:17pm
tags:
Discovery Labs
Roche extends Illumina offer until late April
Reuters
Monday, March 26, 2012 - 12:16pm
tags:
Roche, M&A, tender offer, Illumina

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.